VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,820,145 | -25.7% | 959,500 | -16.8% | 0.07% | -20.7% |
| Q2 2023 | $34,737,907 | +2.9% | 1,153,700 | +10.6% | 0.09% | -9.4% |
| Q1 2023 | $33,743,315 | -15.9% | 1,043,070 | -25.5% | 0.10% | -23.8% |
| Q4 2022 | $40,118,268 | -57.9% | 1,399,800 | -64.6% | 0.13% | -61.1% |
| Q3 2022 | $95,351,000 | -24.7% | 3,953,200 | -14.5% | 0.32% | -22.5% |
| Q2 2022 | $126,586,000 | +150.5% | 4,623,300 | +250.8% | 0.42% | +180.5% |
| Q1 2022 | $50,541,000 | -24.3% | 1,317,890 | -36.7% | 0.15% | +4.2% |
| Q4 2021 | $66,736,000 | +59.7% | 2,083,550 | +46.9% | 0.14% | +53.8% |
| Q3 2021 | $41,796,000 | +7131.1% | 1,418,240 | +8242.6% | 0.09% | +4550.0% |
| Q2 2021 | $578,000 | -99.1% | 17,000 | -99.1% | 0.00% | -98.8% |
| Q1 2021 | $64,305,000 | -0.9% | 1,978,600 | +9.9% | 0.17% | -9.7% |
| Q4 2020 | $64,865,000 | +1669.4% | 1,800,800 | +1823.9% | 0.19% | +1330.8% |
| Q3 2020 | $3,666,000 | +129.4% | 93,600 | +114.9% | 0.01% | +62.5% |
| Q2 2020 | $1,598,000 | -92.5% | 43,560 | -95.3% | 0.01% | -95.4% |
| Q1 2020 | $21,191,000 | -69.9% | 919,730 | -61.7% | 0.17% | -18.4% |
| Q4 2019 | $70,296,000 | +128.4% | 2,400,804 | +108.4% | 0.21% | +103.8% |
| Q3 2019 | $30,775,000 | +233.0% | 1,152,200 | +218.6% | 0.10% | +246.7% |
| Q2 2019 | $9,243,000 | -86.8% | 361,644 | -88.4% | 0.03% | -86.8% |
| Q1 2019 | $70,063,000 | -14.3% | 3,125,034 | -19.4% | 0.23% | -29.3% |
| Q4 2018 | $81,750,000 | +779.3% | 3,876,244 | +672.2% | 0.32% | +1184.0% |
| Q3 2018 | $9,297,000 | +332.2% | 501,944 | +413.0% | 0.02% | +257.1% |
| Q1 2018 | $2,151,000 | +87.0% | 97,845 | +97.8% | 0.01% | +75.0% |
| Q4 2017 | $1,150,000 | +46.1% | 49,465 | +31.5% | 0.00% | +33.3% |
| Q4 2016 | $787,000 | -31.9% | 37,620 | -9.8% | 0.00% | -40.0% |
| Q2 2016 | $1,155,000 | – | 41,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |